EP3613852A3
(en)
|
2011-07-22 |
2020-04-22 |
President and Fellows of Harvard College |
Evaluation and improvement of nuclease cleavage specificity
|
US11021737B2
(en)
|
2011-12-22 |
2021-06-01 |
President And Fellows Of Harvard College |
Compositions and methods for analyte detection
|
GB201122458D0
(en)
|
2011-12-30 |
2012-02-08 |
Univ Wageningen |
Modified cascade ribonucleoproteins and uses thereof
|
US9637739B2
(en)
|
2012-03-20 |
2017-05-02 |
Vilnius University |
RNA-directed DNA cleavage by the Cas9-crRNA complex
|
EP2847335B1
(en)
|
2012-04-25 |
2018-06-27 |
Regeneron Pharmaceuticals, Inc. |
Nuclease-mediated targeting with large targeting vectors
|
WO2013163628A2
(en)
|
2012-04-27 |
2013-10-31 |
Duke University |
Genetic correction of mutated genes
|
PE20150336A1
(es)
|
2012-05-25 |
2015-03-25 |
Univ California |
Metodos y composiciones para la modificacion de adn objetivo dirigida por arn y para la modulacion de la transcripcion dirigida por arn
|
US20150225734A1
(en)
|
2012-06-19 |
2015-08-13 |
Regents Of The University Of Minnesota |
Gene targeting in plants using dna viruses
|
EP3808844A1
(en)
*
|
2012-07-25 |
2021-04-21 |
The Broad Institute, Inc. |
Inducible dna binding proteins and genome perturbation tools and applications thereof
|
CN116064533A
(zh)
|
2012-10-23 |
2023-05-05 |
基因工具股份有限公司 |
用于切割靶dna的组合物及其用途
|
KR101844123B1
(ko)
*
|
2012-12-06 |
2018-04-02 |
시그마-알드리치 컴퍼니., 엘엘씨 |
Crispr-기초된 유전체 변형과 조절
|
WO2014093694A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes
|
ES2786193T3
(es)
|
2012-12-12 |
2020-10-09 |
Broad Inst Inc |
Modificación por tecnología genética y optimización de sistemas, métodos y composiciones enzimáticas mejorados para la manipulación de secuencias
|
ES2553782T3
(es)
*
|
2012-12-12 |
2015-12-11 |
The Broad Institute, Inc. |
Ingeniería de sistemas, métodos y composiciones de guía optimizadas para manipulación de secuencias
|
MX2015007550A
(es)
*
|
2012-12-12 |
2017-02-02 |
Broad Inst Inc |
Suministro, modificación y optimización de sistemas, métodos y composiciones para la manipulación de secuencias y aplicaciones terapéuticas.
|
DK2931898T3
(en)
|
2012-12-12 |
2016-06-20 |
Massachusetts Inst Technology |
CONSTRUCTION AND OPTIMIZATION OF SYSTEMS, PROCEDURES AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH FUNCTIONAL DOMAINS
|
EP2848690B1
(en)
|
2012-12-12 |
2020-08-19 |
The Broad Institute, Inc. |
Crispr-cas component systems, methods and compositions for sequence manipulation
|
EP3434776A1
(en)
|
2012-12-12 |
2019-01-30 |
The Broad Institute, Inc. |
Methods, models, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof
|
US8697359B1
(en)
*
|
2012-12-12 |
2014-04-15 |
The Broad Institute, Inc. |
CRISPR-Cas systems and methods for altering expression of gene products
|
EP3252160B1
(en)
*
|
2012-12-12 |
2020-10-28 |
The Broad Institute, Inc. |
Crispr-cas component systems, methods and compositions for sequence manipulation
|
RU2699523C2
(ru)
*
|
2012-12-17 |
2019-09-05 |
Президент Энд Фэллоуз Оф Харвард Коллидж |
Рнк-направляемая инженерия генома человека
|
EP3578666A1
(en)
|
2013-03-12 |
2019-12-11 |
President and Fellows of Harvard College |
Method of generating a three-dimensional nucleic acid containing matrix
|
ES2901396T3
(es)
|
2013-03-14 |
2022-03-22 |
Caribou Biosciences Inc |
Composiciones y métodos de ácidos nucleicos dirigidos a ácido nucleico
|
US20140273235A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Regents Of The University Of Minnesota |
ENGINEERING PLANT GENOMES USING CRISPR/Cas SYSTEMS
|
WO2014165825A2
(en)
*
|
2013-04-04 |
2014-10-09 |
President And Fellows Of Harvard College |
Therapeutic uses of genome editing with crispr/cas systems
|
PT3456831T
(pt)
|
2013-04-16 |
2021-09-10 |
Regeneron Pharma |
Modificação alvejada do genoma de rato
|
US20160186208A1
(en)
*
|
2013-04-16 |
2016-06-30 |
Whitehead Institute For Biomedical Research |
Methods of Mutating, Modifying or Modulating Nucleic Acid in a Cell or Nonhuman Mammal
|
WO2014186686A2
(en)
*
|
2013-05-17 |
2014-11-20 |
Two Blades Foundation |
Targeted mutagenesis and genome engineering in plants using rna-guided cas nucleases
|
EP3004349B1
(en)
*
|
2013-05-29 |
2018-03-28 |
Cellectis S.A. |
A method for producing precise dna cleavage using cas9 nickase activity
|
US9267135B2
(en)
|
2013-06-04 |
2016-02-23 |
President And Fellows Of Harvard College |
RNA-guided transcriptional regulation
|
EP3603679B1
(en)
*
|
2013-06-04 |
2022-08-10 |
President and Fellows of Harvard College |
Rna-guided transcriptional regulation
|
AU2014279694B2
(en)
|
2013-06-14 |
2020-07-23 |
Cellectis |
Methods for non-transgenic genome editing in plants
|
ES2777217T3
(es)
|
2013-06-17 |
2020-08-04 |
Broad Inst Inc |
Suministro, modificación y optimización de sistemas de guía en tándem, métodos y composiciones para la manipulación de secuencias
|
SG11201510286QA
(en)
|
2013-06-17 |
2016-01-28 |
Broad Inst Inc |
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using viral components
|
DK3011031T3
(da)
|
2013-06-17 |
2020-12-21 |
Broad Inst Inc |
Fremføring og anvendelse af crispr-cas-systemerne, vektorer og sammensætninger til levermålretning og -terapi
|
KR20160034901A
(ko)
|
2013-06-17 |
2016-03-30 |
더 브로드 인스티튜트, 인코퍼레이티드 |
서열 조작에 최적화된 crispr-cas 이중 닉카아제 시스템, 방법 및 조성물
|
EP3011033B1
(en)
|
2013-06-17 |
2020-02-19 |
The Broad Institute, Inc. |
Functional genomics using crispr-cas systems, compositions methods, screens and applications thereof
|
KR20160029112A
(ko)
*
|
2013-07-09 |
2016-03-14 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
멀티플렉스 rna-가이드된 게놈 조작
|
WO2015006498A2
(en)
|
2013-07-09 |
2015-01-15 |
President And Fellows Of Harvard College |
Therapeutic uses of genome editing with crispr/cas systems
|
US11306328B2
(en)
|
2013-07-26 |
2022-04-19 |
President And Fellows Of Harvard College |
Genome engineering
|
US9163284B2
(en)
|
2013-08-09 |
2015-10-20 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a Cas9 nuclease
|
SG11201601927SA
(en)
|
2013-08-16 |
2016-04-28 |
Massachusetts Inst Technology |
Selective delivery of material to cells
|
LT3036327T
(lt)
|
2013-08-22 |
2019-06-25 |
Pioneer Hi-Bred International, Inc. |
Genomo modifikacijos, panaudojant nukreipiančias polinukleotido/cas endonukleazės sistemas, ir panaudojimo būdai
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
US9737604B2
(en)
|
2013-09-06 |
2017-08-22 |
President And Fellows Of Harvard College |
Use of cationic lipids to deliver CAS9
|
US9340800B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
Extended DNA-sensing GRNAS
|
US9388430B2
(en)
|
2013-09-06 |
2016-07-12 |
President And Fellows Of Harvard College |
Cas9-recombinase fusion proteins and uses thereof
|
CN105637087A
(zh)
|
2013-09-18 |
2016-06-01 |
科马布有限公司 |
方法、细胞与生物体
|
WO2015065964A1
(en)
|
2013-10-28 |
2015-05-07 |
The Broad Institute Inc. |
Functional genomics using crispr-cas systems, compositions, methods, screens and applications thereof
|
WO2015066119A1
(en)
|
2013-10-30 |
2015-05-07 |
North Carolina State University |
Compositions and methods related to a type-ii crispr-cas system in lactobacillus buchneri
|
CN106459995B
(zh)
|
2013-11-07 |
2020-02-21 |
爱迪塔斯医药有限公司 |
使用统治型gRNA的CRISPR相关方法和组合物
|
US10787684B2
(en)
*
|
2013-11-19 |
2020-09-29 |
President And Fellows Of Harvard College |
Large gene excision and insertion
|
CN105980568B
(zh)
|
2013-12-11 |
2019-12-03 |
瑞泽恩制药公司 |
用于靶向修饰基因组的方法和组合物
|
SI3080279T1
(sl)
|
2013-12-11 |
2019-01-31 |
Regeneron Pharmaceuticals, Inc. |
Postopki in sestavki za ciljano spremembo genoma
|
US20150166984A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting alpha-antitrypsin point mutations
|
WO2015089364A1
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Crystal structure of a crispr-cas system, and uses thereof
|
AU2014361834B2
(en)
|
2013-12-12 |
2020-10-22 |
Massachusetts Institute Of Technology |
CRISPR-Cas systems and methods for altering expression of gene products, structural information and inducible modular Cas enzymes
|
JP6625055B2
(ja)
|
2013-12-12 |
2020-01-08 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
組成物、及びヌクレオチドリピート障害におけるcrispr−cas系の使用方法
|
WO2015089486A2
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Systems, methods and compositions for sequence manipulation with optimized functional crispr-cas systems
|
DK3079725T3
(da)
|
2013-12-12 |
2020-01-20 |
Broad Inst Inc |
Administration, brug og terapeutiske anvendelser af crispr-cas-systemerne og sammensætninger til genomredigering
|
US10787654B2
(en)
|
2014-01-24 |
2020-09-29 |
North Carolina State University |
Methods and compositions for sequence guiding Cas9 targeting
|
CN111705365A
(zh)
|
2014-02-11 |
2020-09-25 |
科罗拉多州立大学董事会(法人团体) |
Crispr支持的多路基因组工程化
|
KR20160130392A
(ko)
|
2014-02-18 |
2016-11-11 |
듀크 유니버시티 |
바이러스 복제의 불활성화를 위한 조성물 및 그의 제조 및 사용 방법
|
US11186843B2
(en)
|
2014-02-27 |
2021-11-30 |
Monsanto Technology Llc |
Compositions and methods for site directed genomic modification
|
EP3957735A1
(en)
|
2014-03-05 |
2022-02-23 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating usher syndrome and retinitis pigmentosa
|
DK3116997T3
(da)
|
2014-03-10 |
2019-08-19 |
Editas Medicine Inc |
Crispr/cas-relaterede fremgangsmåder og sammensætninger til behandling af lebers kongenitale amaurose 10 (lca10)
|
US11141493B2
(en)
|
2014-03-10 |
2021-10-12 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
US11339437B2
(en)
|
2014-03-10 |
2022-05-24 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
EP3122880B1
(en)
|
2014-03-26 |
2021-05-05 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating sickle cell disease
|
CN106460003A
(zh)
|
2014-04-08 |
2017-02-22 |
北卡罗来纳州立大学 |
用于使用crispr相关基因rna引导阻遏转录的方法和组合物
|
EP3152221A4
(en)
*
|
2014-05-20 |
2018-01-24 |
Regents of the University of Minnesota |
Method for editing a genetic sequence
|
WO2015183025A1
(ko)
*
|
2014-05-28 |
2015-12-03 |
주식회사 툴젠 |
표적 특이적 뉴클레아제를 이용한 표적 dna의 민감한 검출 방법
|
US9970001B2
(en)
|
2014-06-05 |
2018-05-15 |
Sangamo Therapeutics, Inc. |
Methods and compositions for nuclease design
|
LT3152312T
(lt)
|
2014-06-06 |
2020-04-27 |
Regeneron Pharmaceuticals, Inc. |
Tikslinio lokuso modifikavimo būdai ir kompozicijos
|
WO2015191693A2
(en)
|
2014-06-10 |
2015-12-17 |
Massachusetts Institute Of Technology |
Method for gene editing
|
EP3154694A1
(en)
|
2014-06-13 |
2017-04-19 |
Children's Medical Center Corporation |
Products and methods to isolate mitochondria
|
PT3155099T
(pt)
|
2014-06-23 |
2018-04-20 |
Regeneron Pharma |
Montagem de dna mediada por nuclease
|
WO2015200555A2
(en)
*
|
2014-06-25 |
2015-12-30 |
Caribou Biosciences, Inc. |
Rna modification to engineer cas9 activity
|
US20150376587A1
(en)
*
|
2014-06-25 |
2015-12-31 |
Caribou Biosciences, Inc. |
RNA Modification to Engineer Cas9 Activity
|
RU2771532C2
(ru)
|
2014-06-26 |
2022-05-05 |
Регенерон Фармасьютикалз, Инк. |
Способы и композиции для нацеленных генетических модификаций и способы их применения
|
WO2016007347A1
(en)
|
2014-07-11 |
2016-01-14 |
E. I. Du Pont De Nemours And Company |
Compositions and methods for producing plants resistant to glyphosate herbicide
|
WO2016011080A2
(en)
*
|
2014-07-14 |
2016-01-21 |
The Regents Of The University Of California |
Crispr/cas transcriptional modulation
|
EP3172321B2
(en)
*
|
2014-07-21 |
2023-01-04 |
Illumina, Inc. |
Polynucleotide enrichment using crispr-cas systems
|
WO2016022363A2
(en)
|
2014-07-30 |
2016-02-11 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
CN113789317B
(zh)
*
|
2014-08-06 |
2024-02-23 |
基因工具股份有限公司 |
使用空肠弯曲杆菌crispr/cas系统衍生的rna引导的工程化核酸酶的基因编辑
|
EP3194578B1
(en)
|
2014-08-06 |
2021-03-10 |
College of Medicine Pochon Cha University Industry-Academic Cooperation Foundation |
Immune-compatible cells created by nuclease-mediated editing of genes encoding hla
|
WO2016025759A1
(en)
|
2014-08-14 |
2016-02-18 |
Shen Yuelei |
Dna knock-in system
|
SG11201701245QA
(en)
*
|
2014-08-27 |
2017-03-30 |
Caribou Biosciences Inc |
Methods for increasing cas9-mediated engineering efficiency
|
EP3633032A3
(en)
|
2014-08-28 |
2020-07-29 |
North Carolina State University |
Novel cas9 proteins and guiding features for dna targeting and genome editing
|
WO2016036754A1
(en)
|
2014-09-02 |
2016-03-10 |
The Regents Of The University Of California |
Methods and compositions for rna-directed target dna modification
|
EP3191595B1
(en)
|
2014-09-12 |
2019-12-25 |
E. I. du Pont de Nemours and Company |
Generation of site-specific-integration sites for complex trait loci in corn and soybean, and methods of use
|
CN104212836A
(zh)
*
|
2014-09-18 |
2014-12-17 |
东华大学 |
一种在哺乳动物细胞系中敲除mir-505的方法
|
SG11201702309RA
(en)
|
2014-10-15 |
2017-04-27 |
Regeneron Pharma |
Methods and compositions for generating or maintaining pluripotent cells
|
CN107109487B
(zh)
|
2014-10-15 |
2022-03-04 |
赛琪科学股份有限公司 |
自动处理核酸和电泳样品制备的装置、方法和系统
|
SG11201703044PA
(en)
|
2014-10-31 |
2017-05-30 |
Massachusetts Inst Technology |
Delivery of biomolecules to immune cells
|
CN107406838A
(zh)
*
|
2014-11-06 |
2017-11-28 |
纳幕尔杜邦公司 |
Rna引导的内切核酸酶向细胞中的肽介导的递送
|
CA2963820A1
(en)
|
2014-11-07 |
2016-05-12 |
Editas Medicine, Inc. |
Methods for improving crispr/cas-mediated genome-editing
|
US11352666B2
(en)
|
2014-11-14 |
2022-06-07 |
Institute For Basic Science |
Method for detecting off-target sites of programmable nucleases in a genome
|
WO2016076672A1
(ko)
*
|
2014-11-14 |
2016-05-19 |
기초과학연구원 |
유전체에서 유전자 가위의 비표적 위치를 검출하는 방법
|
KR20230070319A
(ko)
|
2014-11-21 |
2023-05-22 |
리제너론 파마슈티칼스 인코포레이티드 |
쌍 형성된 가이드 rna를 사용하는 표적화된 유전자 변형을 위한 방법 및 조성물
|
CA2969619A1
(en)
|
2014-12-03 |
2016-06-09 |
Agilent Technologies, Inc. |
Guide rna with chemical modifications
|
JP6830437B2
(ja)
|
2014-12-10 |
2021-02-17 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
疾患を処置するための遺伝子改変された細胞、組織および臓器
|
WO2016094867A1
(en)
|
2014-12-12 |
2016-06-16 |
The Broad Institute Inc. |
Protected guide rnas (pgrnas)
|
EP3234150A1
(en)
|
2014-12-16 |
2017-10-25 |
Danisco US Inc. |
Fungal genome modification systems and methods of use
|
EP3234133B1
(en)
*
|
2014-12-18 |
2020-11-11 |
Integrated DNA Technologies, Inc. |
Crispr-based compositions and methods of use
|
WO2016100857A1
(en)
|
2014-12-19 |
2016-06-23 |
Regeneron Pharmaceuticals, Inc. |
Stem cells for modeling type 2 diabetes
|
BR112017013104A2
(pt)
|
2014-12-19 |
2018-05-15 |
Regeneron Pharma |
métodos para modificar um locus genômico alvo em uma célula, para intensificar a recombinação homóloga em um locus genômico alvo em uma célula e para produzir uma geração f0 de um animal não humano.
|
CN107250373A
(zh)
*
|
2015-01-12 |
2017-10-13 |
麻省理工学院 |
通过微流体递送实现的基因编辑
|
WO2016155482A1
(zh)
*
|
2015-03-16 |
2016-10-06 |
中国科学院遗传与发育生物学研究所 |
一种利用非遗传物质对植物基因组进行定点改造的方法
|
WO2016150855A1
(en)
*
|
2015-03-20 |
2016-09-29 |
Danmarks Tekniske Universitet |
Crispr/cas9 based engineering of actinomycetal genomes
|
WO2016154579A2
(en)
*
|
2015-03-26 |
2016-09-29 |
Editas Medicine, Inc. |
Crispr/cas-mediated gene conversion
|
US10450576B2
(en)
|
2015-03-27 |
2019-10-22 |
E I Du Pont De Nemours And Company |
Soybean U6 small nuclear RNA gene promoters and their use in constitutive expression of small RNA genes in plants
|
EP3280803B1
(en)
|
2015-04-06 |
2021-05-26 |
The Board of Trustees of the Leland Stanford Junior University |
Chemically modified guide rnas for crispr/cas-mediated gene regulation
|
JP2018522249A
(ja)
|
2015-04-24 |
2018-08-09 |
エディタス・メディシン、インコーポレイテッド |
Cas9分子/ガイドrna分子複合体の評価
|
WO2016182959A1
(en)
|
2015-05-11 |
2016-11-17 |
Editas Medicine, Inc. |
Optimized crispr/cas9 systems and methods for gene editing in stem cells
|
KR101785847B1
(ko)
|
2015-05-12 |
2017-10-17 |
연세대학교 산학협력단 |
선형 이중가닥 DNA를 활용한 CRISPR/Cas9 시스템을 이용한 표적 유전체 교정
|
EP3095870A1
(en)
|
2015-05-19 |
2016-11-23 |
Kws Saat Se |
Methods for the in planta transformation of plants and manufacturing processes and products based and obtainable therefrom
|
EP3303607A4
(en)
|
2015-05-29 |
2018-10-10 |
North Carolina State University |
Methods for screening bacteria, archaea, algae, and yeast using crispr nucleic acids
|
CN108368502B
(zh)
|
2015-06-03 |
2022-03-18 |
内布拉斯加大学董事委员会 |
使用单链dna的dna编辑
|
CN108026526B
(zh)
|
2015-06-09 |
2023-05-12 |
爱迪塔斯医药公司 |
用于改善移植的crispr/cas相关方法和组合物
|
CA2983874C
(en)
|
2015-06-15 |
2022-06-21 |
North Carolina State University |
Methods and compositions for efficient delivery of nucleic acids and rna-based antimicrobials
|
WO2016205759A1
(en)
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation
|
WO2016205613A1
(en)
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Crispr enzyme mutations reducing off-target effects
|
AU2016285724A1
(en)
|
2015-06-29 |
2017-11-16 |
Ionis Pharmaceuticals, Inc. |
Modified CRISPR RNA and modified single CRISPR RNA and uses thereof
|
CA2988996A1
(en)
|
2015-07-09 |
2017-01-12 |
Massachusetts Institute Of Technology |
Delivery of materials to anucleate cells
|
DK3329001T3
(da)
*
|
2015-07-28 |
2021-12-20 |
Danisco Us Inc |
Genomredigeringssystemer og anvendelsesfremgangsmåder
|
CN108472314A
(zh)
|
2015-07-31 |
2018-08-31 |
明尼苏达大学董事会 |
修饰的细胞和治疗方法
|
US9580727B1
(en)
|
2015-08-07 |
2017-02-28 |
Caribou Biosciences, Inc. |
Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides
|
JP2018529759A
(ja)
|
2015-08-14 |
2018-10-11 |
ザ ユニバーシティー オブ シドニー |
治療用コネキシン45阻害剤
|
JP6905755B2
(ja)
|
2015-08-25 |
2021-07-21 |
デューク ユニバーシティ |
Rnaガイド型エンドヌクレアーゼを使用してゲノム工学における特異性を改善する組成物および方法
|
WO2017041051A1
(en)
|
2015-09-04 |
2017-03-09 |
Sqz Biotechnologies Company |
Intracellular delivery of biomolecules to cells comprising a cell wall
|
EP3352795B1
(en)
*
|
2015-09-21 |
2020-08-12 |
The Regents of The University of California |
Compositions and methods for target nucleic acid modification
|
EP3786294A1
(en)
|
2015-09-24 |
2021-03-03 |
Editas Medicine, Inc. |
Use of exonucleases to improve crispr/cas-mediated genome editing
|
EP3356533A1
(en)
|
2015-09-28 |
2018-08-08 |
North Carolina State University |
Methods and compositions for sequence specific antimicrobials
|
WO2017061806A1
(en)
*
|
2015-10-06 |
2017-04-13 |
Institute For Basic Science |
Method for producing whole plants from protoplasts
|
EP4089175A1
(en)
|
2015-10-13 |
2022-11-16 |
Duke University |
Genome engineering with type i crispr systems in eukaryotic cells
|
AU2016341041A1
(en)
*
|
2015-10-20 |
2018-03-15 |
Pioneer Hi-Bred International, Inc. |
Methods and compositions for marker-free genome modification
|
US9677090B2
(en)
|
2015-10-23 |
2017-06-13 |
Caribou Biosciences, Inc. |
Engineered nucleic-acid targeting nucleic acids
|
IL258821B
(en)
|
2015-10-23 |
2022-07-01 |
Harvard College |
Nucleobase editors and their uses
|
WO2017079406A1
(en)
|
2015-11-03 |
2017-05-11 |
President And Fellows Of Harvard College |
Method and apparatus for volumetric imaging of a three-dimensional nucleic acid containing matrix
|
KR101885901B1
(ko)
|
2015-11-13 |
2018-08-07 |
기초과학연구원 |
5' 말단의 인산기가 제거된 rna를 포함하는 리보핵산단백질 전달용 조성물
|
AU2016357319B2
(en)
*
|
2015-11-20 |
2022-03-10 |
Sage Science, Inc. |
Preparative electrophoretic method for targeted purification of genomic DNA fragments
|
US11903974B2
(en)
|
2015-11-30 |
2024-02-20 |
Flagship Pioneering Innovations V, Inc. |
Methods and compositions relating to chondrisomes from cultured cells
|
CN106811479B
(zh)
*
|
2015-11-30 |
2019-10-25 |
中国农业科学院作物科学研究所 |
利用CRISPR/Cas9系统定点修饰ALS基因获得抗除草剂水稻的系统及其应用
|
KR102093570B1
(ko)
*
|
2015-12-04 |
2020-03-25 |
카리부 바이오사이언시스 인코포레이티드 |
조작된 핵산 표적화 핵산
|
CN106845151B
(zh)
*
|
2015-12-07 |
2019-03-26 |
中国农业大学 |
CRISPR-Cas9系统sgRNA作用靶点的筛选方法及装置
|
WO2017099494A1
(ko)
*
|
2015-12-08 |
2017-06-15 |
기초과학연구원 |
Cpf1을 포함하는 유전체 교정용 조성물 및 그 용도
|
WO2017112620A1
(en)
|
2015-12-22 |
2017-06-29 |
North Carolina State University |
Methods and compositions for delivery of crispr based antimicrobials
|
IL260532B2
(en)
|
2016-01-11 |
2023-12-01 |
Univ Leland Stanford Junior |
Systems containing chaperone proteins and their uses for controlling gene expression
|
SG10202112024PA
(en)
|
2016-01-11 |
2021-12-30 |
Univ Leland Stanford Junior |
Chimeric proteins and methods of immunotherapy
|
WO2017124086A1
(en)
*
|
2016-01-15 |
2017-07-20 |
The Jackson Laboratory |
Genetically modified non-human mammals by multi-cycle electroporation of cas9 protein
|
US11597924B2
(en)
|
2016-03-25 |
2023-03-07 |
Editas Medicine, Inc. |
Genome editing systems comprising repair-modulating enzyme molecules and methods of their use
|
US11512311B2
(en)
|
2016-03-25 |
2022-11-29 |
Editas Medicine, Inc. |
Systems and methods for treating alpha 1-antitrypsin (A1AT) deficiency
|
EP3436077A1
(en)
*
|
2016-03-30 |
2019-02-06 |
Intellia Therapeutics, Inc. |
Lipid nanoparticle formulations for crispr/cas components
|
EP3443086B1
(en)
|
2016-04-13 |
2021-11-24 |
Editas Medicine, Inc. |
Cas9 fusion molecules, gene editing systems, and methods of use thereof
|
CA3210120C
(en)
|
2016-04-25 |
2024-04-09 |
President And Fellows Of Harvard College |
Hybridization chain reaction methods for in situ molecular detection
|
CN107326046A
(zh)
*
|
2016-04-28 |
2017-11-07 |
上海邦耀生物科技有限公司 |
一种提高外源基因同源重组效率的方法
|
WO2017201476A1
(en)
|
2016-05-20 |
2017-11-23 |
Regeneron Pharmaceuticals, Inc. |
Methods for breaking immunological tolerance using multiple guide rnas
|
WO2017205846A1
(en)
*
|
2016-05-27 |
2017-11-30 |
Aadigen, Llc |
Peptides and nanoparticles for intracellular delivery of genome-editing molecules
|
AU2017274145B2
(en)
|
2016-06-02 |
2020-07-23 |
Sigma-Aldrich Co Llc |
Using programmable DNA binding proteins to enhance targeted genome modification
|
US10767175B2
(en)
|
2016-06-08 |
2020-09-08 |
Agilent Technologies, Inc. |
High specificity genome editing using chemically modified guide RNAs
|
WO2017217768A1
(ko)
*
|
2016-06-15 |
2017-12-21 |
주식회사 툴젠 |
온타겟 및 오프타겟의 다중 타겟 시스템을 이용하는, 표적 특이적 유전자 가위 스크리닝 방법 및 이의 용도
|
US20190330603A1
(en)
*
|
2016-06-17 |
2019-10-31 |
Genesis Technologies Limited |
Crispr-cas system, materials and methods
|
US11788083B2
(en)
|
2016-06-17 |
2023-10-17 |
The Broad Institute, Inc. |
Type VI CRISPR orthologs and systems
|
IL263595B2
(en)
*
|
2016-06-20 |
2023-11-01 |
Keygene Nv |
A method for targeted modification of DNA in plant cells
|
EP3474669B1
(en)
|
2016-06-24 |
2022-04-06 |
The Regents of The University of Colorado, A Body Corporate |
Methods for generating barcoded combinatorial libraries
|
AU2017292772A1
(en)
*
|
2016-07-05 |
2019-02-21 |
The Johns Hopkins University |
CRISPR-Cas9-based compositions and methods for treating cancer
|
CN109689856A
(zh)
|
2016-07-13 |
2019-04-26 |
帝斯曼知识产权资产管理有限公司 |
用于海藻宿主细胞的CRISPR-Cas系统
|
JP7004651B2
(ja)
*
|
2016-07-19 |
2022-02-04 |
株式会社バイオダイナミクス研究所 |
長鎖一本鎖dnaを調製する方法
|
CN109789185A
(zh)
|
2016-07-28 |
2019-05-21 |
基础科学研究院 |
用于治疗眼部疾病的含cas9蛋白和向导rna的药物组合物
|
WO2018023014A1
(en)
|
2016-07-29 |
2018-02-01 |
Regeneron Pharmaceuticals, Inc. |
Mice comprising mutations resulting in expression of c-truncated fibrillin-1
|
EP3494220A1
(en)
|
2016-08-02 |
2019-06-12 |
Editas Medicine, Inc. |
Compositions and methods for treating cep290 associated disease
|
US11078481B1
(en)
|
2016-08-03 |
2021-08-03 |
KSQ Therapeutics, Inc. |
Methods for screening for cancer targets
|
SG11201900907YA
(en)
|
2016-08-03 |
2019-02-27 |
Harvard College |
Adenosine nucleobase editors and uses thereof
|
US11661590B2
(en)
|
2016-08-09 |
2023-05-30 |
President And Fellows Of Harvard College |
Programmable CAS9-recombinase fusion proteins and uses thereof
|
KR101710026B1
(ko)
|
2016-08-10 |
2017-02-27 |
주식회사 무진메디 |
Cas9 단백질 및 가이드 RNA의 혼성체를 함유하는 나노 리포좀 전달체 조성물
|
KR101856345B1
(ko)
*
|
2016-08-24 |
2018-06-20 |
경상대학교산학협력단 |
CRISPR/Cas9 시스템을 이용하여 APOBEC3H 및 APOBEC3CH 이중-넉아웃 고양이를 제조하는 방법
|
US11542509B2
(en)
|
2016-08-24 |
2023-01-03 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
US11078483B1
(en)
|
2016-09-02 |
2021-08-03 |
KSQ Therapeutics, Inc. |
Methods for measuring and improving CRISPR reagent function
|
US20190225974A1
(en)
*
|
2016-09-23 |
2019-07-25 |
BASF Agricultural Solutions Seed US LLC |
Targeted genome optimization in plants
|
US11242542B2
(en)
|
2016-10-07 |
2022-02-08 |
Integrated Dna Technologies, Inc. |
S. pyogenes Cas9 mutant genes and polypeptides encoded by same
|
KR102606680B1
(ko)
|
2016-10-07 |
2023-11-27 |
인티그레이티드 디엔에이 테크놀로지스 아이엔씨. |
S. 피오게네스 cas9 돌연변이 유전자 및 이에 의해 암호화되는 폴리펩티드
|
GB2573062A
(en)
|
2016-10-14 |
2019-10-23 |
Harvard College |
AAV delivery of nucleobase editors
|
KR101997116B1
(ko)
|
2016-10-14 |
2019-07-05 |
연세대학교 산학협력단 |
Kras 유전자에 상보적인 가이드 rna 및 이의 용도
|
EP4338799A3
(en)
|
2016-10-18 |
2024-06-05 |
Regents of the University of Minnesota |
Tumor infiltrating lymphocytes and methods of therapy
|
WO2018144097A1
(en)
|
2016-11-04 |
2018-08-09 |
Akeagen Llc |
Genetically modified non-human animals and methods for producing heavy chain-only antibodies
|
AU2017355507B2
(en)
|
2016-11-04 |
2023-09-21 |
Flagship Pioneering Innovations V. Inc. |
Novel plant cells, plants, and seeds
|
CN110248957B
(zh)
*
|
2016-11-14 |
2023-12-19 |
株式会社图尔金 |
经人工操纵的sc功能控制系统
|
EP4321617A3
(en)
|
2016-11-22 |
2024-04-24 |
Integrated DNA Technologies Inc. |
Crispr/cpf1 systems and methods
|
US11293022B2
(en)
|
2016-12-12 |
2022-04-05 |
Integrated Dna Technologies, Inc. |
Genome editing enhancement
|
KR101748575B1
(ko)
*
|
2016-12-16 |
2017-06-20 |
주식회사 엠젠플러스 |
Ins 유전자 녹아웃 당뇨병 또는 당뇨병 합병증 동물모델 및 이의 제조방법
|
EA202091316A1
(ru)
*
|
2016-12-22 |
2020-08-18 |
Тулджин Инкорпорейтид |
Обогащенный олеиновой кислотой растительный организм, имеющий генетически модифицированный fad2, и способ его получения
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
CN110300802A
(zh)
*
|
2016-12-23 |
2019-10-01 |
基础科学研究院 |
用于动物胚胎碱基编辑的组合物和碱基编辑方法
|
JP6994730B2
(ja)
*
|
2016-12-26 |
2022-02-04 |
独立行政法人酒類総合研究所 |
ゲノム編集タンパク質の直接導入による糸状菌ゲノム編集方法
|
US11859219B1
(en)
|
2016-12-30 |
2024-01-02 |
Flagship Pioneering Innovations V, Inc. |
Methods of altering a target nucleotide sequence with an RNA-guided nuclease and a single guide RNA
|
KR102515727B1
(ko)
*
|
2017-01-11 |
2023-03-30 |
주식회사 툴젠 |
중첩된 가이드핵산을 이용한 표적 핵산에 특정 핵산 서열을 삽입하기 위한 조성물 및 방법
|
WO2018136702A1
(en)
|
2017-01-23 |
2018-07-26 |
Regeneron Pharmaceuticals, Inc. |
Hydroxysteroid 17-beta dehydrogenase 13 (hsd17b13) variants and uses thereof
|
WO2018140899A1
(en)
|
2017-01-28 |
2018-08-02 |
Inari Agriculture, Inc. |
Novel plant cells, plants, and seeds
|
TW201839136A
(zh)
|
2017-02-06 |
2018-11-01 |
瑞士商諾華公司 |
治療血色素異常症之組合物及方法
|
JP2020508693A
(ja)
*
|
2017-03-06 |
2020-03-26 |
インスティテュート フォー ベーシック サイエンスInstitute For Basic Science |
C2c1エンドヌクレアーゼを含むゲノム編集用組成物およびこれを用いたゲノム編集方法
|
EP3592853A1
(en)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Suppression of pain by gene editing
|
WO2018165629A1
(en)
|
2017-03-10 |
2018-09-13 |
President And Fellows Of Harvard College |
Cytosine to guanine base editor
|
WO2018170184A1
(en)
|
2017-03-14 |
2018-09-20 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
CA3057192A1
(en)
|
2017-03-23 |
2018-09-27 |
President And Fellows Of Harvard College |
Nucleobase editors comprising nucleic acid programmable dna binding proteins
|
CN110506203A
(zh)
|
2017-04-07 |
2019-11-26 |
塞奇科学股份有限公司 |
用于通过使用集成电泳dna纯化来检测遗传结构变异的系统和方法
|
AU2018251150B2
(en)
*
|
2017-04-13 |
2024-05-09 |
Albert-Ludwigs-Universität Freiburg |
New sequence specific reagents targeting CCR5 in primary hematopoietic cells
|
WO2018195129A1
(en)
|
2017-04-17 |
2018-10-25 |
University Of Maryland, College Park |
Embryonic cell cultures and methods of using the same
|
WO2018201086A1
(en)
|
2017-04-28 |
2018-11-01 |
Editas Medicine, Inc. |
Methods and systems for analyzing guide rna molecules
|
WO2018209158A2
(en)
|
2017-05-10 |
2018-11-15 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease systems and methods
|
US11560566B2
(en)
|
2017-05-12 |
2023-01-24 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
|
CN108977442B
(zh)
*
|
2017-06-05 |
2023-01-06 |
广州市锐博生物科技有限公司 |
用于dna编辑的系统及其应用
|
MX2019014661A
(es)
|
2017-06-05 |
2020-07-29 |
Regeneron Pharma |
Variantes de b4galt1 y usos de estas.
|
EP3635104A1
(en)
|
2017-06-09 |
2020-04-15 |
Editas Medicine, Inc. |
Engineered cas9 nucleases
|
AU2018285860A1
(en)
|
2017-06-13 |
2020-01-02 |
Flagship Pioneering Innovations V, Inc. |
Compositions comprising curons and uses thereof
|
JP7275054B2
(ja)
|
2017-06-15 |
2023-05-17 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
標的化された非ウイルスdna挿入
|
US10011849B1
(en)
|
2017-06-23 |
2018-07-03 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
US9982279B1
(en)
|
2017-06-23 |
2018-05-29 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
WO2019006418A2
(en)
|
2017-06-30 |
2019-01-03 |
Intima Bioscience, Inc. |
ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY
|
EP3652312A1
(en)
|
2017-07-14 |
2020-05-20 |
Editas Medicine, Inc. |
Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
|
CN112501254A
(zh)
*
|
2017-07-14 |
2021-03-16 |
上海吐露港生物科技有限公司 |
一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒
|
JP2020534795A
(ja)
|
2017-07-28 |
2020-12-03 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ファージによって支援される連続的進化(pace)を用いて塩基編集因子を進化させるための方法および組成物
|
WO2019028032A1
(en)
|
2017-07-31 |
2019-02-07 |
Regeneron Pharmaceuticals, Inc. |
EMBRYONIC STEM CELLS OF TRANSGENIC MOUSE CASES AND MICE AND USES THEREOF
|
AU2018309708A1
(en)
|
2017-07-31 |
2020-02-06 |
Regeneron Pharmaceuticals, Inc. |
CRISPR reporter non-human animals and uses thereof
|
CA3065579A1
(en)
|
2017-07-31 |
2019-02-07 |
Regeneron Pharmaceuticals, Inc. |
Assessment of crispr/cas-induced recombination with an exogenous donor nucleic acid in vivo
|
EP3663310A4
(en)
|
2017-08-04 |
2021-08-11 |
Peking University |
TALE-RVD WITH SPECIFIC DETECTION OF A DNA BASE MODIFIED BY METHYLATION AND APPLICATION OF IT
|
US11624077B2
(en)
|
2017-08-08 |
2023-04-11 |
Peking University |
Gene knockout method
|
US11319532B2
(en)
|
2017-08-30 |
2022-05-03 |
President And Fellows Of Harvard College |
High efficiency base editors comprising Gam
|
US11713452B2
(en)
|
2017-09-08 |
2023-08-01 |
University Of North Texas Health Science Center |
Engineered CAS9 variants
|
US20200216805A1
(en)
|
2017-09-18 |
2020-07-09 |
Edigene Inc. |
Gene editing t cell and use thereof
|
US11572574B2
(en)
|
2017-09-28 |
2023-02-07 |
Toolgen Incorporated |
Artificial genome manipulation for gene expression regulation
|
CN111527208B
(zh)
*
|
2017-09-28 |
2024-05-14 |
株式会社图尔金 |
用于基因表达调节的人工基因组操纵
|
AU2018339089A1
(en)
|
2017-09-29 |
2020-04-09 |
Intellia Therapeutics, Inc. |
Polynucleotides, compositions, and methods for genome editing
|
CN111163633B
(zh)
|
2017-09-29 |
2022-09-09 |
瑞泽恩制药公司 |
包含人源化ttr基因座的非人类动物及其使用方法
|
KR102207352B1
(ko)
*
|
2017-09-29 |
2021-01-26 |
서울대학교산학협력단 |
Klotho 유전자 넉아웃 질환모델 동물 및 이의 용도
|
US11795443B2
(en)
|
2017-10-16 |
2023-10-24 |
The Broad Institute, Inc. |
Uses of adenosine base editors
|
KR102503130B1
(ko)
|
2017-10-27 |
2023-02-24 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
내인성 t 세포 수용체의 표적화된 대체
|
CN109722414A
(zh)
|
2017-10-27 |
2019-05-07 |
博雅辑因(北京)生物科技有限公司 |
一种高效制备成熟红细胞的方法以及用于制备成熟红细胞的培养基
|
CN108192956B
(zh)
*
|
2017-11-17 |
2021-06-01 |
东南大学 |
一种基于Cas9核酸酶的DNA检测分析方法及其应用
|
AU2018370588B2
(en)
|
2017-11-21 |
2022-09-08 |
Genkore Co. Ltd. |
Composition for Genome Editing Using Crispr/CPF1 System and Use Thereof
|
CN111566121A
(zh)
|
2018-01-12 |
2020-08-21 |
巴斯夫欧洲公司 |
小麦7a染色体上决定每穗小穗数QTL的基因
|
KR20200103769A
(ko)
*
|
2018-01-23 |
2020-09-02 |
기초과학연구원 |
연장된 단일 가이드 rna 및 그 용도
|
US11926835B1
(en)
|
2018-01-29 |
2024-03-12 |
Inari Agriculture Technology, Inc. |
Methods for efficient tomato genome editing
|
WO2019156475A1
(ko)
*
|
2018-02-06 |
2019-08-15 |
주식회사 진씨커 |
돌연변이 세포 유리 유전자 분리 키트 및 이를 이용한 돌연변이 세포 유리 유전자 분리 방법
|
KR102086689B1
(ko)
|
2018-02-06 |
2020-03-09 |
주식회사 진씨커 |
돌연변이 세포 유리 유전자 분리 키트 및 이를 이용한 돌연변이 세포 유리 유전자 분리 방법
|
WO2019183123A1
(en)
|
2018-03-19 |
2019-09-26 |
Regeneron Pharmaceuticals, Inc. |
Transcription modulation in animals using crispr/cas systems
|
JP2021521788A
(ja)
|
2018-04-19 |
2021-08-30 |
ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア |
ゲノム編集のための組成物および方法
|
WO2019206233A1
(zh)
*
|
2018-04-25 |
2019-10-31 |
中国农业大学 |
一种RNA编辑的CRISPR/Cas效应蛋白及系统
|
JP2021523745A
(ja)
|
2018-05-16 |
2021-09-09 |
シンテゴ コーポレイション |
ガイドrna設計および使用のための方法およびシステム
|
US11866719B1
(en)
|
2018-06-04 |
2024-01-09 |
Inari Agriculture Technology, Inc. |
Heterologous integration of regulatory elements to alter gene expression in wheat cells and wheat plants
|
KR102035654B1
(ko)
*
|
2018-07-23 |
2019-10-24 |
대한민국 |
항균 펩타이드를 생산하는 돌연변이 곤충 세포주 또는 이의 제조방법
|
US11479762B1
(en)
|
2018-08-31 |
2022-10-25 |
Inari Agriculture Technology, Inc. |
Compositions, systems, and methods for genome editing
|
JP7410154B2
(ja)
*
|
2018-09-12 |
2024-01-09 |
インスティチュート フォー ベーシック サイエンス |
遺伝的に変異された細胞の死滅誘導組成物及び該組成物を用いた遺伝的に変異された細胞の死滅誘導方法
|
WO2020072248A1
(en)
|
2018-10-01 |
2020-04-09 |
North Carolina State University |
Recombinant type i crispr-cas system
|
KR102081962B1
(ko)
*
|
2018-10-11 |
2020-02-26 |
충남대학교 산학협력단 |
아밀로이드 전구 단백질 유전자를 절단하기 위한 조성물
|
CN113260701A
(zh)
|
2018-10-18 |
2021-08-13 |
英特利亚治疗股份有限公司 |
用于表达因子ix的组合物和方法
|
JP2022505381A
(ja)
|
2018-10-18 |
2022-01-14 |
インテリア セラピューティクス,インコーポレーテッド |
アルファ1アンチトリプシン欠乏症を治療するための組成物及び方法
|
KR20210102882A
(ko)
|
2018-10-18 |
2021-08-20 |
인텔리아 테라퓨틱스, 인크. |
핵산 구조체 및 사용 방법
|
KR20210102883A
(ko)
|
2018-10-18 |
2021-08-20 |
인텔리아 테라퓨틱스, 인크. |
알부민 좌위로부터 트랜스진을 발현하기 위한 조성물 및 방법
|
CN113106081A
(zh)
*
|
2018-10-29 |
2021-07-13 |
中国农业大学 |
新型CRISPR/Cas12f酶和系统
|
EP3874048A1
(en)
*
|
2018-11-01 |
2021-09-08 |
Keygene N.V. |
Dual guide rna for crispr/cas genome editing in plants cells
|
EP3650557B1
(en)
*
|
2018-11-07 |
2021-10-20 |
Justus-Liebig-Universität Gießen |
Method for determination of restriction efficiency of endonucleases mediating double-strand breaks in dna target sequences
|
JP7426101B2
(ja)
*
|
2018-11-16 |
2024-02-01 |
国立大学法人大阪大学 |
ゲノム編集された細胞を製造する方法
|
KR20200071198A
(ko)
|
2018-12-10 |
2020-06-19 |
네오이뮨텍, 인코퍼레이티드 |
Nrf2 발현 조절 기반 T 세포 항암면역치료법
|
US11166996B2
(en)
|
2018-12-12 |
2021-11-09 |
Flagship Pioneering Innovations V, Inc. |
Anellovirus compositions and methods of use
|
CN113423823A
(zh)
*
|
2018-12-12 |
2021-09-21 |
国立大学法人九州大学 |
经基因组编辑的细胞的制造方法
|
US20220073890A1
(en)
|
2018-12-14 |
2022-03-10 |
Pioneer Hi-Bred International, Inc. |
Novel crispr-cas systems for genome editing
|
JP7449291B2
(ja)
|
2018-12-20 |
2024-03-13 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
ヌクレアーゼ媒介リピート伸長
|
JP2022516647A
(ja)
*
|
2019-01-07 |
2022-03-01 |
クリスプ-エイチアール セラピューティクス, インコーポレイテッド |
非毒性cas9酵素およびその用途
|
CN109868275A
(zh)
*
|
2019-03-12 |
2019-06-11 |
中国农业大学 |
CRISPR/Cas9介导的羊FGF5基因敲除和定点整合MTNR1A基因的方法
|
US11781131B2
(en)
|
2019-03-18 |
2023-10-10 |
Regeneron Pharmaceuticals, Inc. |
CRISPR/Cas dropout screening platform to reveal genetic vulnerabilities associated with tau aggregation
|
CN113631700A
(zh)
|
2019-03-18 |
2021-11-09 |
瑞泽恩制药公司 |
用于鉴定tau接种或聚集的基因修饰因子的CRISPR/Cas筛选平台
|
WO2020191153A2
(en)
|
2019-03-19 |
2020-09-24 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
MX2021011956A
(es)
|
2019-04-03 |
2021-12-15 |
Regeneron Pharma |
Metodos y composiciones para la insercion de secuencias codificantes de anticuerpos en un locus de puerto seguro.
|
KR102487901B1
(ko)
|
2019-04-04 |
2023-01-12 |
리제너론 파마슈티칼스 인코포레이티드 |
표적화된 변형의 표적화 벡터로의 무흔적 도입을 위한 방법
|
WO2020206139A1
(en)
|
2019-04-04 |
2020-10-08 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized coagulation factor 12 locus
|
US20220193142A1
(en)
|
2019-04-30 |
2022-06-23 |
Edigene Inc. |
Method for predicting effectiveness of treatment of hemoglobinopathy
|
US11692197B2
(en)
|
2019-05-06 |
2023-07-04 |
Inari Agriculture Technology, Inc. |
Delivery of biological molecules to plant cells
|
JP2022534867A
(ja)
|
2019-06-04 |
2022-08-04 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
ベータスリップ変異を有するヒト化ttr遺伝子座を含む非ヒト動物と使用方法
|
CN111304180B
(zh)
*
|
2019-06-04 |
2023-05-26 |
山东舜丰生物科技有限公司 |
一种新的dna核酸切割酶及其应用
|
BR112021022722A2
(pt)
|
2019-06-07 |
2022-01-04 |
Regeneron Pharma |
Animal não humano, célula de animal não humana, genoma de animal não humano, gene de albumina animal não humana humanizada, vetor de alvejamento, método de avaliação da atividade de um reagente, e, método de otimização da atividade de um reagente
|
EP3813522A1
(en)
|
2019-06-14 |
2021-05-05 |
Regeneron Pharmaceuticals, Inc. |
Models of tauopathy
|
SG11202112092TA
(en)
|
2019-06-25 |
2021-11-29 |
Inari Agriculture Technology Inc |
Improved homology dependent repair genome editing
|
CN115244176A
(zh)
*
|
2019-08-19 |
2022-10-25 |
钟明宏 |
向导rna-cas蛋白复合物的缀合物
|
JP2022547105A
(ja)
|
2019-09-04 |
2022-11-10 |
博雅▲輯▼因(北京)生物科技有限公司 |
オフターゲット評価に基づく遺伝子編集治療の評価方法
|
CN114616002A
(zh)
|
2019-09-13 |
2022-06-10 |
瑞泽恩制药公司 |
使用由脂质纳米颗粒递送的crispr/cas系统在动物中进行的转录调控
|
JP2022548399A
(ja)
|
2019-09-23 |
2022-11-18 |
オメガ セラピューティクス, インコーポレイテッド |
肝細胞核因子4-アルファ(HNF4α)遺伝子発現をモジュレートするための組成物および方法
|
EP4048807A1
(en)
|
2019-09-23 |
2022-08-31 |
Omega Therapeutics, Inc. |
Compositions and methods for modulating apolipoprotein b (apob) gene expression
|
WO2021067788A1
(en)
|
2019-10-03 |
2021-04-08 |
Artisan Development Labs, Inc. |
Crispr systems with engineered dual guide nucleic acids
|
IL292434A
(en)
*
|
2019-11-05 |
2022-06-01 |
Pairwise Plants Services Inc |
Preparations and methods for replacing DNA encoded by rna of alleles
|
EP4054651A1
(en)
|
2019-11-08 |
2022-09-14 |
Regeneron Pharmaceuticals, Inc. |
Crispr and aav strategies for x-linked juvenile retinoschisis therapy
|
JP7448120B2
(ja)
*
|
2019-11-14 |
2024-03-12 |
国立研究開発法人農業・食品産業技術総合研究機構 |
プラズマを用いてゲノム編集酵素を植物細胞内に導入する方法
|
WO2021108363A1
(en)
|
2019-11-25 |
2021-06-03 |
Regeneron Pharmaceuticals, Inc. |
Crispr/cas-mediated upregulation of humanized ttr allele
|
WO2021108442A2
(en)
*
|
2019-11-27 |
2021-06-03 |
The Regents Of The University Of California |
Modulators of cas9 polypeptide activity and methods of use thereof
|
US20230059884A1
(en)
|
2019-12-30 |
2023-02-23 |
Edigene Biotechnology Inc. |
Universal car-t targeting t-cell lymphoma cell and preparation method therefor and use thereof
|
US20230054266A1
(en)
|
2019-12-30 |
2023-02-23 |
Edigene Biotechnology Inc. |
Method for purifying ucart cell and use thereof
|
KR102616080B1
(ko)
|
2020-01-14 |
2023-12-21 |
주식회사 툴젠 |
알츠하이머 예방 또는 치료용 약학적 조성물 및 이의 용도
|
CA3167681A1
(en)
*
|
2020-01-14 |
2021-07-22 |
Toolgen Incorporated |
Cells having high adaptability under hypoxic conditions, and use thereof
|
WO2021163515A1
(en)
*
|
2020-02-12 |
2021-08-19 |
Temple University - Of The Commonwealth System Of Higher Education |
Crispr-cas9 mediated disruption of alcam gene inhibits adhesion and trans-endothelial migration of myeloid cells
|
KR20210109384A
(ko)
|
2020-02-27 |
2021-09-06 |
주식회사 엘지화학 |
원형질체를 활용한 식물 유전자 교정 효율 증대 방법
|
WO2021178556A1
(en)
|
2020-03-04 |
2021-09-10 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for sensitization of tumor cells to immune therapy
|
WO2021183720A1
(en)
|
2020-03-11 |
2021-09-16 |
Omega Therapeutics, Inc. |
Compositions and methods for modulating forkhead box p3 (foxp3) gene expression
|
EP4125348A1
(en)
|
2020-03-23 |
2023-02-08 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized ttr locus comprising a v30m mutation and methods of use
|
US20210319851A1
(en)
|
2020-04-03 |
2021-10-14 |
Creyon Bio, Inc. |
Oligonucleotide-based machine learning
|
KR20230019843A
(ko)
|
2020-05-08 |
2023-02-09 |
더 브로드 인스티튜트, 인코퍼레이티드 |
표적 이중 가닥 뉴클레오티드 서열의 두 가닥의 동시 편집을 위한 방법 및 조성물
|
CN111690720B
(zh)
*
|
2020-06-16 |
2021-06-15 |
山东舜丰生物科技有限公司 |
利用修饰的单链核酸进行靶核酸检测的方法
|
WO2022120022A1
(en)
|
2020-12-02 |
2022-06-09 |
Regeneron Pharmaceuticals, Inc. |
Crispr sam biosensor cell lines and methods of use thereof
|
WO2022124839A1
(ko)
*
|
2020-12-09 |
2022-06-16 |
재단법인 아산사회복지재단 |
온-타겟 활성이 유지되고 오프-타겟 활성이 감소된 가이드 rna 및 이의 용도
|
CA3206361A1
(en)
|
2020-12-23 |
2022-06-30 |
Flagship Pioneering Innovations V, Inc. |
In vitro assembly of anellovirus capsids enclosing rna
|
TW202235615A
(zh)
|
2020-12-30 |
2022-09-16 |
美商英特利亞醫療公司 |
工程化之t細胞
|
KR102285906B1
(ko)
*
|
2021-02-18 |
2021-08-04 |
주식회사 엔에이피 |
수생태계 교란어종 관리를 위한 큰입배스 불임 유도용 조성물
|
CA3218511A1
(en)
|
2021-05-10 |
2022-11-17 |
Sqz Biotechnologies Company |
Methods for delivering genome editing molecules to the nucleus or cytosol of a cell and uses thereof
|
KR102616916B1
(ko)
*
|
2021-05-11 |
2023-12-21 |
주식회사 애이마 |
발암성 돌연변이 유전자 검출용 가이드 rna 내지 이의 용도
|
WO2022251644A1
(en)
|
2021-05-28 |
2022-12-01 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
WO2022256448A2
(en)
|
2021-06-01 |
2022-12-08 |
Artisan Development Labs, Inc. |
Compositions and methods for targeting, editing, or modifying genes
|
EP4347826A1
(en)
|
2021-06-02 |
2024-04-10 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
KR102618072B1
(ko)
|
2021-06-15 |
2023-12-28 |
대한민국 |
작물의 개화조절 관련 유전자 교정용 가이드 rna 및 이의 용도
|
EP4370676A2
(en)
|
2021-06-18 |
2024-05-22 |
Artisan Development Labs, Inc. |
Compositions and methods for targeting, editing or modifying human genes
|
EP4367242A2
(en)
|
2021-07-07 |
2024-05-15 |
Omega Therapeutics, Inc. |
Compositions and methods for modulating secreted frizzled receptor protein 1 (sfrp1) gene expression
|
KR20230010617A
(ko)
|
2021-07-09 |
2023-01-19 |
주식회사 툴젠 |
산화스트레스 저항성을 갖는 중간엽줄기세포, 이의 제조방법 및 용도
|
KR20230019791A
(ko)
|
2021-07-29 |
2023-02-09 |
주식회사 툴젠 |
혈액 적합성을 갖는 중간엽 줄기세포, 이의 제조방법 및 용도
|
CN113584134B
(zh)
*
|
2021-09-06 |
2024-01-30 |
青岛金斯达生物技术有限公司 |
一种基于CRISPR-Cas9的等温核酸检测系统及其方法和应用
|
US11884915B2
(en)
|
2021-09-10 |
2024-01-30 |
Agilent Technologies, Inc. |
Guide RNAs with chemical modification for prime editing
|
WO2023064924A1
(en)
|
2021-10-14 |
2023-04-20 |
Codiak Biosciences, Inc. |
Modified producer cells for extracellular vesicle production
|
WO2023077053A2
(en)
|
2021-10-28 |
2023-05-04 |
Regeneron Pharmaceuticals, Inc. |
Crispr/cas-related methods and compositions for knocking out c5
|
WO2023077148A1
(en)
|
2021-11-01 |
2023-05-04 |
Tome Biosciences, Inc. |
Single construct platform for simultaneous delivery of gene editing machinery and nucleic acid cargo
|
CA3238939A1
(en)
|
2021-12-08 |
2023-06-15 |
Gaurang Patel |
Mutant myocilin disease model and uses thereof
|
WO2023122764A1
(en)
|
2021-12-22 |
2023-06-29 |
Tome Biosciences, Inc. |
Co-delivery of a gene editor construct and a donor template
|
WO2023122800A1
(en)
|
2021-12-23 |
2023-06-29 |
University Of Massachusetts |
Therapeutic treatment for fragile x-associated disorder
|
WO2023129974A1
(en)
|
2021-12-29 |
2023-07-06 |
Bristol-Myers Squibb Company |
Generation of landing pad cell lines
|
WO2023150181A1
(en)
|
2022-02-01 |
2023-08-10 |
President And Fellows Of Harvard College |
Methods and compositions for treating cancer
|
WO2023150623A2
(en)
|
2022-02-02 |
2023-08-10 |
Regeneron Pharmaceuticals, Inc. |
Anti-tfr:gaa and anti-cd63:gaa insertion for treatment of pompe disease
|
WO2023167882A1
(en)
|
2022-03-01 |
2023-09-07 |
Artisan Development Labs, Inc. |
Composition and methods for transgene insertion
|
CN114410609B
(zh)
*
|
2022-03-29 |
2022-07-12 |
舜丰生物科技(海南)有限公司 |
一种活性提高的Cas蛋白以及应用
|
WO2023205744A1
(en)
|
2022-04-20 |
2023-10-26 |
Tome Biosciences, Inc. |
Programmable gene insertion compositions
|
WO2023205844A1
(en)
*
|
2022-04-26 |
2023-11-02 |
Peter Maccallum Cancer Institute |
Nucleic acids and uses thereof
|
WO2023212677A2
(en)
|
2022-04-29 |
2023-11-02 |
Regeneron Pharmaceuticals, Inc. |
Identification of tissue-specific extragenic safe harbors for gene therapy approaches
|
WO2023215831A1
(en)
|
2022-05-04 |
2023-11-09 |
Tome Biosciences, Inc. |
Guide rna compositions for programmable gene insertion
|
WO2023220603A1
(en)
|
2022-05-09 |
2023-11-16 |
Regeneron Pharmaceuticals, Inc. |
Vectors and methods for in vivo antibody production
|
WO2023225665A1
(en)
|
2022-05-19 |
2023-11-23 |
Lyell Immunopharma, Inc. |
Polynucleotides targeting nr4a3 and uses thereof
|
WO2023225670A2
(en)
|
2022-05-20 |
2023-11-23 |
Tome Biosciences, Inc. |
Ex vivo programmable gene insertion
|
WO2023225410A2
(en)
|
2022-05-20 |
2023-11-23 |
Artisan Development Labs, Inc. |
Systems and methods for assessing risk of genome editing events
|
WO2023230549A2
(en)
|
2022-05-25 |
2023-11-30 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods for modulation of tumor suppressors and oncogenes
|
WO2023230570A2
(en)
|
2022-05-25 |
2023-11-30 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods for modulating genetic drivers
|
WO2023230573A2
(en)
|
2022-05-25 |
2023-11-30 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods for modulation of immune responses
|
WO2023230566A2
(en)
|
2022-05-25 |
2023-11-30 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods for modulating cytokines
|
WO2023230578A2
(en)
|
2022-05-25 |
2023-11-30 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods for modulating circulating factors
|
WO2023235725A2
(en)
|
2022-05-31 |
2023-12-07 |
Regeneron Pharmaceuticals, Inc. |
Crispr-based therapeutics for c9orf72 repeat expansion disease
|
WO2023235726A2
(en)
|
2022-05-31 |
2023-12-07 |
Regeneron Pharmaceuticals, Inc. |
Crispr interference therapeutics for c9orf72 repeat expansion disease
|
WO2024006955A1
(en)
|
2022-06-29 |
2024-01-04 |
Intellia Therapeutics, Inc. |
Engineered t cells
|
WO2024005863A1
(en)
|
2022-06-30 |
2024-01-04 |
Inari Agriculture Technology, Inc. |
Compositions, systems, and methods for genome editing
|
WO2024005864A1
(en)
|
2022-06-30 |
2024-01-04 |
Inari Agriculture Technology, Inc. |
Compositions, systems, and methods for genome editing
|
EP4299733A1
(en)
|
2022-06-30 |
2024-01-03 |
Inari Agriculture Technology, Inc. |
Compositions, systems, and methods for genome editing
|
EP4299739A1
(en)
|
2022-06-30 |
2024-01-03 |
Inari Agriculture Technology, Inc. |
Compositions, systems, and methods for genome editing
|
WO2024020587A2
(en)
|
2022-07-22 |
2024-01-25 |
Tome Biosciences, Inc. |
Pleiopluripotent stem cell programmable gene insertion
|
WO2024026474A1
(en)
|
2022-07-29 |
2024-02-01 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for transferrin receptor (tfr)-mediated delivery to the brain and muscle
|
WO2024031053A1
(en)
|
2022-08-05 |
2024-02-08 |
Regeneron Pharmaceuticals, Inc. |
Aggregation-resistant variants of tdp-43
|
CN115386597A
(zh)
*
|
2022-09-19 |
2022-11-25 |
国家纳米科学中心 |
一种提高基因载体转染效率和/或转染精度的转染辅助试剂及其应用
|
WO2024064958A1
(en)
|
2022-09-23 |
2024-03-28 |
Lyell Immunopharma, Inc. |
Methods for culturing nr4a-deficient cells
|
WO2024064952A1
(en)
|
2022-09-23 |
2024-03-28 |
Lyell Immunopharma, Inc. |
Methods for culturing nr4a-deficient cells overexpressing c-jun
|
WO2024073606A1
(en)
|
2022-09-28 |
2024-04-04 |
Regeneron Pharmaceuticals, Inc. |
Antibody resistant modified receptors to enhance cell-based therapies
|
WO2024077174A1
(en)
|
2022-10-05 |
2024-04-11 |
Lyell Immunopharma, Inc. |
Methods for culturing nr4a-deficient cells
|
WO2024098002A1
(en)
|
2022-11-04 |
2024-05-10 |
Regeneron Pharmaceuticals, Inc. |
Calcium voltage-gated channel auxiliary subunit gamma 1 (cacng1) binding proteins and cacng1-mediated delivery to skeletal muscle
|
WO2024102434A1
(en)
|
2022-11-10 |
2024-05-16 |
Senda Biosciences, Inc. |
Rna compositions comprising lipid nanoparticles or lipid reconstructed natural messenger packs
|
WO2024107765A2
(en)
|
2022-11-14 |
2024-05-23 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for fibroblast growth factor receptor 3-mediated delivery to astrocytes
|